Literature DB >> 33087264

DNA mismatch repair-dependent DNA damage responses and cancer.

Robbert Ijsselsteijn1, Jacob G Jansen1, Niels de Wind2.   

Abstract

Canonical DNA mismatch repair (MMR) excises base-base mismatches to increase the fidelity of DNA replication. Thus, loss of MMR leads to increased spontaneous mutagenesis. MMR genes also are involved in the suppression of mutagenic, and the induction of protective, responses to various types of DNA damage. In this review we describe these non-canonical roles of MMR at different lesion types. Loss of non-canonical MMR gene functions may have important ramifications for the prevention, development and treatment of colorectal cancer associated with inherited MMR gene defects in Lynch syndrome. This graphical review pays tribute to Samuel H. Wilson. Sam not only made seminal contributions to understanding base excision repair, particularly with respect to structure-function relationships in DNA polymerase β but also, as Editor of DNA Repair, has maintained a high standard of the journal.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; DNA damage responses; DNA mismatch repair; Mutagenesis

Mesh:

Substances:

Year:  2020        PMID: 33087264     DOI: 10.1016/j.dnarep.2020.102923

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  16 in total

1.  Polo-like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancer.

Authors:  Zhengang Duan; Lei Cai; Jin Cao; Wei Wu
Journal:  Oncol Lett       Date:  2022-06-20       Impact factor: 3.111

2.  Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer.

Authors:  Dingli Song; Dai Zhang; Sisi Chen; Jie Wu; Qian Hao; Lili Zhao; Hong Ren; Ning Du
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

Review 3.  Zebrafish Cancer Predisposition Models.

Authors:  Kim Kobar; Keon Collett; Sergey V Prykhozhij; Jason N Berman
Journal:  Front Cell Dev Biol       Date:  2021-04-27

4.  Identification of molecular subtypes and prognostic signature for hepatocellular carcinoma based on genes associated with homologous recombination deficiency.

Authors:  Hongsheng Lin; Yangyi Xie; Yinzhi Kong; Li Yang; Mingfen Li
Journal:  Sci Rep       Date:  2021-12-15       Impact factor: 4.379

5.  Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma.

Authors:  Heng Zhang; Qiang Ju; Jing Ji; Yanjie Zhao
Journal:  Dis Markers       Date:  2021-10-26       Impact factor: 3.434

6.  The Clinical Significance and Potential Molecular Mechanism of Upregulated CDC28 Protein Kinase Regulatory Subunit 1B in Osteosarcoma.

Authors:  Chaohua Mo; Le Xie; Chang Chen; Jie Ma; Yingxin Huang; Yanxing Wu; Yuanyuan Xu; Huizhi Peng; Zengwei Chen; Rongjun Mao
Journal:  J Oncol       Date:  2021-12-10       Impact factor: 4.375

7.  Aggresome-Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma.

Authors:  Zhiyong Zhang; Xin Zhang; Aimin Huang
Journal:  Front Oncol       Date:  2021-08-17       Impact factor: 6.244

8.  N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma.

Authors:  Zhiying Zhao; Qiang Ju; Jing Ji; Yutong Li; Yanjie Zhao
Journal:  Front Mol Biosci       Date:  2022-02-09

Review 9.  DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.

Authors:  Ruixue Huang; Ping-Kun Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-09

Review 10.  The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer.

Authors:  Yichi Xu; Gendi Song; Shangdan Xie; Wenxiao Jiang; Xin Chen; Man Chu; Xiaoli Hu; Zhi-Wei Wang
Journal:  Mol Ther       Date:  2021-04-29       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.